| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.1B | $16.1B | $14.4B | $3.4B | $3.4B | $3.6B | $5.1B | — |
| Cost of Revenue | $14.9B | $15.0B | $13.4B | $3.2B | $3.1B | $3.4B | $4.9B | — |
| Gross Profit | $1.2B | $1.1B | $0.9B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.0B | $0.8B | $0.3B | $0.2B | $0.2B | $0.1B | $-0.4B | $0.2B |
| Net Income | $0.6B | $0.4B | $0.1B | $0.1B | $0.1B | $-0.2B | $-0.5B | $0.1B |
| EPS (Basic) | $4.24 | $2.97 | $0.40 | $0.76 | $0.67 | $-1.44 | $-3.01 | $0.53 |
| EPS (Diluted) | $4.21 | $2.95 | $0.39 | $0.75 | $0.66 | $-1.44 | $-3.01 | $0.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.2B | $12.1B | $11.2B | $11.1B | $11.7B | $13.0B | $14.5B | $14.7B |
| Current Assets | $6.7B | $7.2B | $6.2B | $5.8B | $6.2B | $7.5B | $7.5B | $7.1B |
| Cash & Equivalents | $1.6B | $1.6B | $1.3B | $1.2B | $1.2B | $1.7B | $1.1B | $0.9B |
| Total Liabilities | $9.5B | $9.7B | $8.8B | $8.5B | $8.9B | $9.6B | $10.6B | $10.4B |
| Current Liabilities | $5.9B | $6.4B | $5.9B | $5.4B | $5.5B | $6.1B | $6.5B | $6.1B |
| Stockholders' Equity | $2.5B | $2.2B | $2.2B | $2.5B | $2.7B | $3.3B | $3.7B | $4.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.8B | $0.7B | $0.7B | $0.7B | $0.3B | $0.8B | $0.8B |
| Investing Cash Flow | $-0.4B | $-0.2B | $-0.1B | $-0.2B | $-0.4B | $2.0B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.4B | $-0.3B | $-0.5B | $-0.6B | $-0.9B | $-1.6B | $-0.4B | $-0.6B |